GABAA receptor agonist
| GABAA receptor agonist | |
|---|---|
| Drug class | |
| Class identifiers | |
| Synonyms | GABAA agonist |
| Use | Seizures, insomnia, hallucinogenic effects |
| Mechanism of action | GABAA receptor agonism |
| Biological target | GABAA receptor |
| Chemical class | GABA analogues and others |
| Legal status | |
| In Wikidata | |
A GABAA receptor agonist is a drug that acts as an orthosteric agonist of the GABAA receptor, the major signaling receptor of the inhibitory neurotransmitter γ-aminobutyric acid (GABA).
The mechanism of action of GABAA receptor agonists is unlike that of GABAA positive allosteric modulators, including benzodiazepines, Z drugs, barbiturates, neurosteroids, and alcohol, which instead act via allosteric regulatory sites to potentiate GABAA receptor function. GABAA receptor agonists have different effects from those of GABAA receptor positive allosteric modulators.
Examples of GABAA receptor agonists include GABA itself, γ-amino-β-hydroxybutyric acid (GABOB), muscimol (found in Amanita muscaria mushrooms), gaboxadol (THIP), and progabide, among others. High-efficacy GABAA receptor agonists have been found to produce sedative, hypnotic, anticonvulsant, and hallucinogenic effects, among others. The structural requirements for GABAA receptor binding and activation have been found to be very strict, so relatively few high-efficacy GABAA receptor agonists are known. No fully selective GABAA receptor agonists, for instance lacking any additional activity at the closely related GABAA-ρ and/or GABAB receptors, are currently known.
GABAA receptor agonists are generally GABA analogues and derivatives. Muscimol, a conformationally restrained analogue of GABA, was among the first GABAA receptor agonists to be identified.